Adjuvant endocrine therapy for post-menopausal women with ductal carcinoma in situ-is the pain worth the gain?-A commentary on the NSABP-B35 trial

Kirsty E. Stuart, John Boyages

Research output: Contribution to journalComment/opinionResearchpeer-review

LanguageEnglish
PagesS113-S116
Number of pages4
JournalTranslational Cancer Research
Volume5
DOIs
Publication statusPublished - Jun 2016

Cite this

@article{7bdcc012a0574cbc98897e887f2d1024,
title = "Adjuvant endocrine therapy for post-menopausal women with ductal carcinoma in situ-is the pain worth the gain?-A commentary on the NSABP-B35 trial",
author = "Stuart, {Kirsty E.} and John Boyages",
year = "2016",
month = "6",
doi = "10.21037/tcr.2016.06.11",
language = "English",
volume = "5",
pages = "S113--S116",
journal = "Translational Cancer Research",
issn = "2218-676X",
publisher = "AME Publishing Company",

}

Adjuvant endocrine therapy for post-menopausal women with ductal carcinoma in situ-is the pain worth the gain?-A commentary on the NSABP-B35 trial. / Stuart, Kirsty E.; Boyages, John.

In: Translational Cancer Research, Vol. 5, 06.2016, p. S113-S116.

Research output: Contribution to journalComment/opinionResearchpeer-review

TY - JOUR

T1 - Adjuvant endocrine therapy for post-menopausal women with ductal carcinoma in situ-is the pain worth the gain?-A commentary on the NSABP-B35 trial

AU - Stuart, Kirsty E.

AU - Boyages, John

PY - 2016/6

Y1 - 2016/6

UR - http://www.scopus.com/inward/record.url?scp=84991794209&partnerID=8YFLogxK

U2 - 10.21037/tcr.2016.06.11

DO - 10.21037/tcr.2016.06.11

M3 - Comment/opinion

VL - 5

SP - S113-S116

JO - Translational Cancer Research

T2 - Translational Cancer Research

JF - Translational Cancer Research

SN - 2218-676X

ER -